Visit
0 upvotes
Visit
0 upvotes
Cure Cancer With AI - Product Image

an AI-powered cancer research platform that helps patients, caregivers, and researchers discover and understand clinical trials, scientific studies, FDA updates, and emerging cancer treatments.

About

CureCancerWithAI.com is a free, AI-powered cancer research platform designed to make complex oncology information easier to discover, understand, and use. Built for patients, caregivers, researchers, healthcare professionals, and developers, the platform brings together current cancer research, clinical trials, FDA approvals, medical news, educational resources, and AI-assisted biomedical tools in one centralized experience.

The platform continuously collects and organizes information from trusted sources such as PubMed, ClinicalTrials.gov, openFDA, NCBI databases, and established cancer news publishers. Users can explore research by cancer type, treatment, biomarker, keyword, or publication date; find recruiting clinical trials; follow regulatory developments; and use an AI research assistant to understand technical findings in plain language.

CureCancerWithAI.com also includes a research knowledge graph for discovering connections between studies and oncology topics, personalized research dashboards, email alerts, clinical-trial discovery, daily wellness check-ins, a nonprofit resource directory, and tools for searching multiple biomedical databases.

For developers, researchers, and AI builders, CureCancerWithAI.com provides a free public REST API with structured JSON access to its continuously updated oncology datasets. The API includes endpoints for research papers, cancer news, blog content, FDA oncology approvals, clinical trials, individual study records, and a unified search tool that can query multiple datasets simultaneously. OpenAPI documentation and machine-readable instructions are available to simplify integration into applications, research workflows, and AI systems.

The platform also offers a remote Model Context Protocol (MCP) server. This allows compatible AI assistants and autonomous agents to connect directly to CureCancerWithAI.com and use its oncology search, research, clinical-trial, FDA, and biomedical prediction capabilities as callable tools.

Through its integration with IBM’s MAMMAL biomedical foundation model, the API and MCP server also support experimental predictions involving protein–protein interactions, drug–target binding affinity, and clinical-trial toxicity. Additional pharmaceutical research tools help users search compounds and review molecular characteristics.

CureCancerWithAI.com aims to bridge the gap between rapidly evolving cancer research and the patients, families, scientists, and developers who need access to it. The platform is intended for research and educational purposes and does not provide medical diagnoses or replace guidance from qualified healthcare professionals.

Comments